Atopalm First Aid Triple Antibiotic
NDC Package 51141-3000-1
Package Information
Atopalm First Aid Triple Antibiotic is clean the affected areaapply a small amount of the product (an amount equal to the surface area of the tip of a finger) on the area 1 to 3 times dailymay be covered with a sterile bandagechildren under 2 yrs. Marketed by Neopharm Co., Ltd., this product is identified by NDC 51141-3000 and is authorized under FDA application part333B.
Identification & Billing
- RxCUI: 1294475 - ATOPALM First Aid Triple Antibiotic 400 UNT / 3.5 MG / 5000 UNT per GM Topical Ointment
- RxCUI: 1294475 - bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical Ointment [Atopalm First Aid]
- RxCUI: 1294475 - Atopalm First Aid (bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 5000 UNT per GM) Topical Ointment
- RxCUI: 204602 - bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 5000 UNT per GM Topical Ointment
- RxCUI: 204602 - bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical Ointment
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51141 - Neopharm Co., Ltd.
- 51141-3000 - Atopalm First Aid Triple Antibiotic
- 51141-3000-1 - 1 TUBE in 1 CARTON / 28.3 g in 1 TUBE
- 51141-3000 - Atopalm First Aid Triple Antibiotic
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51141-3000-1 identifies a specific commercial package of 1 tube in 1 carton / 28.3 g in 1 tube of Atopalm First Aid Triple Antibiotic, labeled by Neopharm Co., Ltd.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Neopharm Co., Ltd. on March 16, 2011. The current certification is valid through December 31, 2017.
How is this Neopharm Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51141300001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.